Answer
Yes, neutropenia, including severe neutropenia, has been reported with isatuximab-containing regimens, and complications can include febrile neutropenia and neutropenic infections.
Sources for this answer
- SARCLISA 20mg/mL concentrate for solution for infusionSANOFI · emc · SmPC §4.4 Special warnings and precautions for use · Version 10Document updated
Sources checked